Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study

Khashayar Dashtipour, Zoltan Mari, Joseph Jankovic, Charles Howard Adler, Marc Schwartz, Mitchell F. Brin

Research output: Contribution to journalArticle

Abstract

Objective: To determine the minimal clinically important change (MCIC) on Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores using data from Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE), which captured real-world practices and outcomes. Methods: Changes in the baseline TWSTRS scores (point and percentage changes) were compared to changes in the Patient and Clinician Global Impression of Change (PGIC and CGIC) ratings. Using logistic regression, the discrimination of the model was determined. Results: Among the 479 patients who completed all TWSTRS assessments, the mean TWSTRS Total score significantly decreased from baseline (39.2) to the final visit (27.1) (P <.0001). TWSTRS Total score point changes that compared with PGIC assessments “very much improved,” “much improved” or better, and “minimally improved” or better were −11, −9, and −8, respectively, and were similar to previously published changes (ie, a decrease of ≥10 points). TWSTRS Total score data met indicators of good cutoffs for discrimination of the model including ≥70% percentage of outcomes correctly classified when compared with PGIC ratings. The TWSTRS Total score mapped to PGIC and CGIC ratings better than any TWSTRS subscale score. Conclusions: The MCIC for improvement was ≥8 points based on mean TWSTRS Total scores in patients with cervical dystonia when compared against the patient-based evaluation of benefit (PGIC).

Original languageEnglish (US)
Article number116413
JournalJournal of the neurological sciences
Volume405
DOIs
StatePublished - Oct 15 2019

Fingerprint

Torticollis
Registries
Observation
onabotulinumtoxinA
Logistic Models

Keywords

  • CD PROBE
  • Cervical dystonia
  • Clinical effectiveness
  • OnabotulinumtoxinA

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Minimal clinically important change in patients with cervical dystonia : Results from the CD PROBE study. / Dashtipour, Khashayar; Mari, Zoltan; Jankovic, Joseph; Adler, Charles Howard; Schwartz, Marc; Brin, Mitchell F.

In: Journal of the neurological sciences, Vol. 405, 116413, 15.10.2019.

Research output: Contribution to journalArticle

Dashtipour, Khashayar ; Mari, Zoltan ; Jankovic, Joseph ; Adler, Charles Howard ; Schwartz, Marc ; Brin, Mitchell F. / Minimal clinically important change in patients with cervical dystonia : Results from the CD PROBE study. In: Journal of the neurological sciences. 2019 ; Vol. 405.
@article{e592e284081842288bc7e6f135f60087,
title = "Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study",
abstract = "Objective: To determine the minimal clinically important change (MCIC) on Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores using data from Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE), which captured real-world practices and outcomes. Methods: Changes in the baseline TWSTRS scores (point and percentage changes) were compared to changes in the Patient and Clinician Global Impression of Change (PGIC and CGIC) ratings. Using logistic regression, the discrimination of the model was determined. Results: Among the 479 patients who completed all TWSTRS assessments, the mean TWSTRS Total score significantly decreased from baseline (39.2) to the final visit (27.1) (P <.0001). TWSTRS Total score point changes that compared with PGIC assessments “very much improved,” “much improved” or better, and “minimally improved” or better were −11, −9, and −8, respectively, and were similar to previously published changes (ie, a decrease of ≥10 points). TWSTRS Total score data met indicators of good cutoffs for discrimination of the model including ≥70{\%} percentage of outcomes correctly classified when compared with PGIC ratings. The TWSTRS Total score mapped to PGIC and CGIC ratings better than any TWSTRS subscale score. Conclusions: The MCIC for improvement was ≥8 points based on mean TWSTRS Total scores in patients with cervical dystonia when compared against the patient-based evaluation of benefit (PGIC).",
keywords = "CD PROBE, Cervical dystonia, Clinical effectiveness, OnabotulinumtoxinA",
author = "Khashayar Dashtipour and Zoltan Mari and Joseph Jankovic and Adler, {Charles Howard} and Marc Schwartz and Brin, {Mitchell F.}",
year = "2019",
month = "10",
day = "15",
doi = "10.1016/j.jns.2019.07.031",
language = "English (US)",
volume = "405",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Minimal clinically important change in patients with cervical dystonia

T2 - Results from the CD PROBE study

AU - Dashtipour, Khashayar

AU - Mari, Zoltan

AU - Jankovic, Joseph

AU - Adler, Charles Howard

AU - Schwartz, Marc

AU - Brin, Mitchell F.

PY - 2019/10/15

Y1 - 2019/10/15

N2 - Objective: To determine the minimal clinically important change (MCIC) on Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores using data from Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE), which captured real-world practices and outcomes. Methods: Changes in the baseline TWSTRS scores (point and percentage changes) were compared to changes in the Patient and Clinician Global Impression of Change (PGIC and CGIC) ratings. Using logistic regression, the discrimination of the model was determined. Results: Among the 479 patients who completed all TWSTRS assessments, the mean TWSTRS Total score significantly decreased from baseline (39.2) to the final visit (27.1) (P <.0001). TWSTRS Total score point changes that compared with PGIC assessments “very much improved,” “much improved” or better, and “minimally improved” or better were −11, −9, and −8, respectively, and were similar to previously published changes (ie, a decrease of ≥10 points). TWSTRS Total score data met indicators of good cutoffs for discrimination of the model including ≥70% percentage of outcomes correctly classified when compared with PGIC ratings. The TWSTRS Total score mapped to PGIC and CGIC ratings better than any TWSTRS subscale score. Conclusions: The MCIC for improvement was ≥8 points based on mean TWSTRS Total scores in patients with cervical dystonia when compared against the patient-based evaluation of benefit (PGIC).

AB - Objective: To determine the minimal clinically important change (MCIC) on Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores using data from Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE), which captured real-world practices and outcomes. Methods: Changes in the baseline TWSTRS scores (point and percentage changes) were compared to changes in the Patient and Clinician Global Impression of Change (PGIC and CGIC) ratings. Using logistic regression, the discrimination of the model was determined. Results: Among the 479 patients who completed all TWSTRS assessments, the mean TWSTRS Total score significantly decreased from baseline (39.2) to the final visit (27.1) (P <.0001). TWSTRS Total score point changes that compared with PGIC assessments “very much improved,” “much improved” or better, and “minimally improved” or better were −11, −9, and −8, respectively, and were similar to previously published changes (ie, a decrease of ≥10 points). TWSTRS Total score data met indicators of good cutoffs for discrimination of the model including ≥70% percentage of outcomes correctly classified when compared with PGIC ratings. The TWSTRS Total score mapped to PGIC and CGIC ratings better than any TWSTRS subscale score. Conclusions: The MCIC for improvement was ≥8 points based on mean TWSTRS Total scores in patients with cervical dystonia when compared against the patient-based evaluation of benefit (PGIC).

KW - CD PROBE

KW - Cervical dystonia

KW - Clinical effectiveness

KW - OnabotulinumtoxinA

UR - http://www.scopus.com/inward/record.url?scp=85071716511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071716511&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2019.07.031

DO - 10.1016/j.jns.2019.07.031

M3 - Article

C2 - 31494402

AN - SCOPUS:85071716511

VL - 405

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

M1 - 116413

ER -